Role of Probiotics in Managing of Helicobacter Pylori Infection: A Review

Drug Research

Volumn 67, Issue 2, 2017, Pages 88-93

  Kafshdooz, Taiebeh ^a   Akbarzadeh, Abolfazl ^b   Majdi Seghinsara, Abbas ^c   Pourhassan, Moghadam ^a   Nasrabadi, Hamid Tayefi ^c   Milani, Morteza ^b,d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

gastroprotection; Helicobacter pylori; immune response; probiotics

Indexed keywords

PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; BACTERIAL CLEARANCE; BACTERIAL LOAD; DRUG EFFICACY; DRUG MECHANISM; HELICOBACTER INFECTION; HUMAN; NONHUMAN; REVIEW; STOMACH; SYSTEMATIC REVIEW; ANTIBIOTIC RESISTANCE; COMBINATION DRUG THERAPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MICROBIOLOGY; PEPTIC ULCER; PROCEDURES; TRENDS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; PROBIOTICS;

EID: 84994638543     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0042-116441     Document Type: Review

References (74)

1. Marshall B., Warren J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. The Lancet: 1984; 323 1311 1315
2. Kusters J. G., van Vliet A. H., Kuipers E. J. Pathogenesis of Helicobacter pylori infection. Clinical microbiology reviews: 2006; 19 449 490
3. Ghotaslou R., Milani M., Akhi M. T. et al. Diversity of Helicobacter pylori cagA and vacA genes and its relationship with clinical outcomes in Azerbaijan, Iran. Adv Pharm Bull: 2013; 3 57 62
4. Lee J. H., Jun S. H., Kim J. M. et al. Morphological changes in human gastric epithelial cells induced by nuclear targeting of Helicobacter pylori urease subunit A. Journal of Microbiology: 2015; 53 406 414
5. Dadashzadeh K., Milani M., Rahmati M. et al. Real-Time PCR detection of 16S rRNA novel mutations associated with Helicobacter pylori tetracycline resistance in Iran. Asian Pac J Cancer Prev: 2014; 15 8883 8886
6. Hellmig S., Ott S., Rosenstiel P. et al. Genetic variants in matrix metalloproteinase genes are associated with development of gastric ulcer in H. pylori infection. The American journal of gastroenterology: 2006; 101 29 35
7. Lehours P., Zheng Z., Skoglund A. et al. Is there a link between the lipopolysaccharide of Helicobacter pylori gastric MALT lymphoma associated strains and lymphoma pathogenesis? PLoS One: 2009; 4 e7297
8. Uemura N., Okamoto S., Yamamoto S. et al. Helicobacter pylori infection and the development of gastric cancer. New England Journal of Medicine: 2001; 345 784 789
9. Salihefendic N., Zildzic M., Cabric E. A New Approach to the Management of Uninvestigated Dyspepsia in Primary Care. Medical Archives: 2015; 69 133
10. Yeomans N. D. The ulcer sleuths: The search for the cause of peptic ulcers. Journal of gastroenterology and hepatology: 2011; 26 01 35 41
11. Dixon M. F. IV. Helicobacter pylori and peptic ulceration: Histopathological aspects. Journal of gastroenterology and hepatology: 1991; 6 125 130
12. Ierardi E., Giorgio F., Losurdo G. et al. How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography. World J Gastroenterol: 2013; 19 8168 8180
13. Mégraud F., Lamouliatte H. Helicobacter pylori and duodenal ulcer. Digestive diseases and sciences: 1992; 37 769 772
14. Gong Y., Li Y., Sun Q. Probiotics improve efficacy and tolerability of triple therapy to eradicate Helicobacter pylori: a meta-analysis of randomized controlled trials. International journal of clinical and experimental medicine: 2015; 8 6530
15. Richter J. H pylori: the bug is not all bad. Gut: 2001; 49 319 320
16. Dunn B. E., Campbell G. P., Perez-Perez G. I. et al. Purification and characterization of urease from Helicobacter pylori. Journal of Biological Chemistry: 1990; 265 9464 9469
17. Yamaoka Y., Kodama T., Kita M. et al. Relation between clinical presentation, Helicobacter pylori density, interleukin 1β and 8 production, and cagA status. Gut: 1999; 45 804 811
18. Tokunaga Y., Shirahase H., Hoppou T. et al. Density of Helicobacter pylori infection evaluated semiquantitatively in gastric cancer. Journal of clinical gastroenterology: 2000; 31 217 221
19. Yazbek P. B., Trindade A. B., Chin C. M. et al. Challenges to the treatment and new perspectives for the eradication of helicobacter pylori. Digestive diseases and sciences: 2015; 60 2901 2912
20. Miftahussurur M., Yamaoka Y. Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective. Molecules: 2015; 20 6068 6092
21. Isolauri E., Kirjavainen P., Salminen S. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut: 2002; 50 03 iii54 iii59
22. Marteau P., Seksik P., Jian R. Probiotics and intestinal health effects: a clinical perspective. British Journal of Nutrition: 2002; 88 01 s51 s57
23. Hamilton-Miller J. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. International journal of antimicrobial agents: 2003; 22 360 366
24. Qua C. S., Manikam J., Goh K. L. Efficacy of 1-week proton pump inhibitor triple therapy as first-line Helicobacter pylori eradication regime in Asian patients: Is it still effective 10 years on? Journal of digestive diseases: 2010; 11 244 248
25. Kuo C-H, Kuo F. C., Hu H. M. et al. The optimal first-line therapy of Helicobacter pylori infection in year 2012. Gastroenterol Res pract: 2012; 2012 168361. 10.1155/2012/168361
26. Megraud F. Helicobacter pylori and antibiotic resistance. Gut: 2007; 56 1502
27. Pacifico L., Osborn J. F., Bonci E. et al. Probiotics for the treatment of Helicobacter pylori infection in children. World J Gastroenterol: 2014; 20 673 683
28. Rijkers G. T., de Vos W. M., Brummer R. J. et al. Health benefits and health claims of probiotics: bridging science and marketing. British Journal of Nutrition: 2011; 106 1291 1296
29. Azizpour K., Bahrambeygi S., Mahmoodpour S. et al. History and basic of probiotics. Research Journal of Biological Sciences: 2009; 4 409 426
30. Metschnikoff E., Chalmers P. The prolongation of life. Optimistic studies. London, UK William Heinemann: 1907
31. Sonomoto K., Yokota A. Lactic acid bacteria and bifidobacteria: current progress in advanced research. Horizon Scientific Press: 2011
32. Tannock G. W. Probiotics and prebiotics: scientific aspects. Horizon Scientific Press: 2005
33. Heller K. J. Probiotic bacteria in fermented foods: product characteristics and starter organisms. The American Journal of Clinical Nutrition: 2001; 73 374s 379s
34. Suresh K., Krishnappa S., Bhardwaj P. Safety concerns of Probiotic use: A review. Safety: 2013; 34 40
35. Rijkers G. T., Bengmark S., Enck P. et al. Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. The Journal of nutrition: 2010; 140 671S 676S
36. Rochet V., Rigottier-Gois L., Levenez F. et al. Modulation of Lactobacillus casei in ileal and fecal samples from healthy volunteers after consumption of a fermented milk containing Lactobacillus casei DN-114 001Rif. Canadian journal of microbiology: 2008; 54 660 667
37. Rochet V., Rigottier-Gois L., Ledaire A. et al. Survival of Bifidobacterium animalis DN-173 010 in the faecal microbiota after administration in lyophilised form or in fermented product - a randomised study in healthy adults. Journal of molecular microbiology and biotechnology: 2007; 14 128 136
38. Tuohy K., Pinart-Gilberga M., Jones M. et al. Survivability of a probiotic Lactobacillus casei in the gastrointestinal tract of healthy human volunteers and its impact on the faecal microflora. Journal of applied microbiology: 2007; 102 1026 1032
39. Elli M., Callegari M. L., Ferrari S. et al. Survival of yogurt bacteria in the human gut. Applied and environmental microbiology: 2006; 72 5113 5117
40. Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. The American journal of clinical nutrition: 2001; 73 399s 405s
41. Mättö J., Fondénb R., Tolvanen T. et al. Intestinal survival and persistence of probiotic Lactobacillus and Bifidobacterium strains administered in triple-strain yoghurt. International dairy journal: 2006; 16 1174 1180
42. Johansson M-L, Nobaek S., Berggren A. et al. Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats. International journal of food microbiology: 1998; 42 29 38
43. Goldin B. R., Gorbach S. L., Saxelin M. et al. Survival ofLactobacillus species (strain GG) in human gastrointestinal tract. Digestive diseases and sciences: 1992; 37 121 128
44. Fuller R., Gibson G. R. Probiotics and prebiotics: microflora management for improved gut health. Clinical microbiology and infection: 1998; 4 477 480
45. Rolfe R. D. The role of probiotic cultures in the control of gastrointestinal health. The Journal of nutrition: 2000; 130 396S 402S
46. Avía Y., Suzuki N., Kabir A. M. et al. Lactic acidmediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol: 1998; 93 2097 2101
47. Sgouras D., Maragkoudakis P., Petraki K. et al. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Applied and environmental microbiology: 2004; 70 518 526
48. Cats A., Kuipers E. J., Bosschaert M. A. et al. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Alimentary pharmacology & therapeutics: 2003; 17 429 435
49. Linsalata M., Russo F., Berloco P. et al. The influence of lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in helicobacter pylori-infected gastric mucosa. Helicobacter: 2004; 9 165 172
50. Pantoflickova D., Corthésy-Theulaz I., Dorta G. et al. Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis. Alimentary pharmacology & therapeutics: 2003; 18 805 813
51. Ruggiero P. Use of probiotics in the fight against Helicobacter pylori. World J Gastrointest Pathophysiol: 2014; 5 384 391
52. Gotteland M., Brunser O., Cruchet S. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? Alimentary pharmacology & therapeutics: 2006; 23 1077 1086
53. Sartor R. B. Probiotic therapy of intestinal inflammation and infections. Current opinion in gastroenterology: 2005; 21 44 50
54. Salminen S., Isolauri E., Salminen E. Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie Van Leeuwenhoek: 1996; 70 347 358
55. Ling W. H., Korpela R., Mykkänen H. et al. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. The Journal of nutrition: 1994; 124 18 23
56. Marteau P., Flourie B., Pochart P. et al. Effect of the microbial lactase (EC 3.2. 1.23) activity in yoghurt on the intestinal absorption of lactose: an in vivo study in lactase-deficient humans. British Journal of Nutrition: 1990; 64 71 79
57. Michetti P., Dorta G., Wiesel P. H. et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion: 1999; 60 203 209
58. Canducci F., Armuzzi A., Cremonini F. et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Alimentary pharmacology & therapeutics: 2000; 14 1625 1629
59. Armuzzi A., Cremonini F., Ojetti V. et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion: 2001; 63 1 7
60. Sheu B. S., Wu J. J., Lo C. Y. et al. Impact of supplement with Lactobacillus-and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics: 2002; 16 1669 1675
61. Tursi A., Brandimarte G., Giorgetti G. M. et al. Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Medical Science Monitor: 2004; 10 CR662 CR666
62. Armuzzi A., Cremonini F., Bartolozzi F. et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Alimentary pharmacology & therapeutics: 2001; 15 163 169
63. Cremonini F., Di Caro S., Covino M. et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. The American journal of gastroenterology: 2002; 97 2744 2749
64. Manfredi M., Bizzarri B., Sacchero R. I. et al. Helicobacter pylori infection in clinical practice: probiotics and a combination of probiotics+ lactoferrin improve compliance, but not eradication, in sequential therapy. Helicobacter: 2012; 17 254 263
65. Gisbert J., Khorrami S., Calvet X. et al. Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists - their efficacy with antibiotics in Helicobacter pylori eradication. Alimentary pharmacology & therapeutics: 2003; 18 757 766
66. Myllyluoma E., Veijola L., Ahlroos T. et al. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy - a placebo-controlled, double-blind randomized pilot study. Alimentary pharmacology & therapeutics: 2005; 21 1263 1272
67. Ernst P. B., Gold B. D. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annual Reviews in Microbiology: 2000; 54 615 640
68. Havenaar R., Ten Brink B., Huis J. H. Selection of strains for probiotic use, in Probiotics. Springer: 1992; 209 224
69. Sartor R. B. Enteric microflora in IBD: pathogens or commensals? Inflammatory bowel diseases: 1997; 3 230 235
70. Wang K-Y, Li S. N., Liu C. S. et al. Effects of ingesting Lactobacillus-and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. The American journal of clinical nutrition: 2004; 80 737 741
71. Weizman Z., Asli G., Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics: 2005; 115 5 9
72. Malfertheiner P., Megraud F., O'Morain C. A. et al. Management of Helicobacter pylori infection - the Maastricht IV/Florence consensus report. Gut: 2012; 61 646 664
73. Lu C., Sang J., He H. et al. Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis. Scientific reports: 2016; 6 1 10
74. Zhang M-M, Qian W., Qin Y. Y. et al. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis. World J Gastroenterol: 2015; 21 4345 4357